Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity-Reference-Cited by-同舟云学术

Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity

Published:2011-07 Issue:1-3 Volume:661 Page:27-34
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Peters Matthew F.,Zacco Anna,Gordon John,Maciag Carla M.,Litwin Linda C.,Thompson Carolann,Schroeder Patricia,Sygowski Linda A.,Piser Timothy M.,Brugel Todd A.

Publisher

Elsevier BV

Subject

Pharmacology

Reference28 articles.

1. Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding;Banker;J. Pharm. Sci.,2003

2. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid;Barre;Clin. Chem.,1985

3. Opiate receptors within the blood–brain barrier mediate kappa agonist-induced water diuresis;Brooks;J. Pharmacol. Exp. Ther.,1993

4. Kinase cascades and ligand-directed signaling at the κ-opioid receptor;Bruchas;Psychopharmacology (Berl),2010

5. Long-acting κ-opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase;Bruchas;J. Biol. Chem.,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anxiety Disorders: Treatments, Models, and Circuitry Mechanisms;European Journal of Pharmacology;2024-09

2. Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder;Expert Opinion on Emerging Drugs;2024-05-08

3. A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse;European Journal of Medicinal Chemistry;2022-12

4. Blockade of kappa opioid receptors reduces mechanical hyperalgesia and anxiety-like behavior in a rat model of trigeminal neuropathic pain;Behavioural Brain Research;2022-01

5. Transmucosal Buprenorphine in the Treatment of Dyspnea: Case Series and Review of the Literature;Palliative Medicine Reports;2021-01-01